These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1250 related items for PubMed ID: 25860354

  • 1. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T.
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
    De Fino C, Lucchini M, Lucchetti D, Nociti V, Losavio FA, Bianco A, Colella F, Ricciardi-Tenore C, Sgambato A, Mirabella M.
    Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
    [Abstract] [Full Text] [Related]

  • 3. Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.
    Stilund M, Reuschlein AK, Christensen T, Møller HJ, Rasmussen PV, Petersen T.
    PLoS One; 2014 Oct; 9(6):e98588. PubMed ID: 24886843
    [Abstract] [Full Text] [Related]

  • 4. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P, Losy J, Kramer L, Wójcicka M, Kaufman E.
    J Neurol Sci; 2017 Sep 15; 380():22-26. PubMed ID: 28870573
    [Abstract] [Full Text] [Related]

  • 5. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T, Hatzifilippou E, Arnaoutoglou M, Balogiannis S, Koutsouraki E.
    Hell J Nucl Med; 2019 Sep 15; 22 Suppl 2():113-121. PubMed ID: 31802051
    [Abstract] [Full Text] [Related]

  • 6. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J, Börnsen L, Khademi M, Olsson T, Jensen PE, Sørensen PS, Sellebjerg F.
    Mult Scler; 2013 Jun 15; 19(7):877-84. PubMed ID: 23178691
    [Abstract] [Full Text] [Related]

  • 7. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
    Klíčová K, Mareš J, Sobek O, Rous Z, Rous M, Raška M, Hartung HP.
    Eur J Neurosci; 2024 Jun 15; 59(11):2955-2966. PubMed ID: 38453679
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
    Ottervald J, Franzén B, Nilsson K, Andersson LI, Khademi M, Eriksson B, Kjellström S, Marko-Varga G, Végvári A, Harris RA, Laurell T, Miliotis T, Matusevicius D, Salter H, Ferm M, Olsson T.
    J Proteomics; 2010 Apr 18; 73(6):1117-32. PubMed ID: 20093204
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H.
    Lupus; 2019 Jul 18; 28(8):986-994. PubMed ID: 31246559
    [Abstract] [Full Text] [Related]

  • 10. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis.
    Farrokhi M, Saadatpour Z, Fadaee E, Saadatpour L, Rezaei A, Moeini P, Amani Beni A.
    Iran J Allergy Asthma Immunol; 2016 Dec 18; 15(6):536-546. PubMed ID: 28129686
    [Abstract] [Full Text] [Related]

  • 11. Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.
    Emeršič A, Karikari TK, Kac PR, Gonzalez-Ortiz F, Dulewicz M, Ashton NJ, Brecl Jakob G, Horvat Ledinek A, Hanrieder J, Zetterberg H, Rot U, Čučnik S, Blennow K.
    Mult Scler Relat Disord; 2024 Oct 18; 90():105801. PubMed ID: 39153429
    [Abstract] [Full Text] [Related]

  • 12. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis.
    Marastoni D, Magliozzi R, Bolzan A, Pisani AI, Rossi S, Crescenzo F, Montemezzi S, Pizzini FB, Calabrese M.
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov 18; 8(6):. PubMed ID: 34588298
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic usefulness of sCD163, procalcitonin and neopterin for sepsis risk assessment in critically ill patients.
    Sapa A, Rak A, Wybieralska M, Machoń J, Krzywonos-Zawadzka A, Zawadzki K, Wełna M, Woźniak M.
    Adv Clin Exp Med; 2017 Nov 18; 26(1):101-108. PubMed ID: 28397440
    [Abstract] [Full Text] [Related]

  • 14. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 15. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation.
    Magliozzi R, Pezzini F, Pucci M, Rossi S, Facchiano F, Marastoni D, Montagnana M, Lippi G, Reynolds R, Calabrese M.
    Cells; 2021 Jul 06; 10(7):. PubMed ID: 34359880
    [Abstract] [Full Text] [Related]

  • 16. A multi-biomarker follow-up study of patients with multiple sclerosis.
    Stilund M, Gjelstrup MC, Christensen T, Møller HJ, Petersen T.
    Brain Behav; 2016 Sep 06; 6(9):e00509. PubMed ID: 27688939
    [Abstract] [Full Text] [Related]

  • 17. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 06; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
    Novakova L, Axelsson M, Khademi M, Zetterberg H, Blennow K, Malmeström C, Piehl F, Olsson T, Lycke J.
    J Neurochem; 2017 Apr 06; 141(2):296-304. PubMed ID: 27787906
    [Abstract] [Full Text] [Related]

  • 19. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
    Talbot J, Højsgaard Chow H, Mahler M, Buhelt S, Holm Hansen R, Lundell H, Vinther-Jensen T, Hellem MNN, Nielsen JE, Siebner HR, von Essen MR, Sellebjerg F.
    Mult Scler Relat Disord; 2022 Dec 06; 68():104209. PubMed ID: 36257152
    [Abstract] [Full Text] [Related]

  • 20. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
    Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O.
    J Viral Hepat; 2015 Apr 06; 22(4):427-32. PubMed ID: 25181653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.